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Abstract: Although it is known that individuals with schizophrenia demonstrate marked 
impairment in reinforcement learning, the details of this impairment are not known. The aim 
of this study was to test the hypothesis that reward-related probability learning is altered in 
schizophrenia patients. Twenty-five clinically stable schizophrenia patients and 25 age- and 
gender-matched controls participated in the study. A simple gambling paradigm was used in 
which five different cues were associated with different reward probabilities (50%, 67%, and 
100%). Participants were asked to make their best guess about the reward probability of each 
cue. Compared with controls, patients had significant impairment in learning contingencies on 
the basis of reward-related feedback. The correlation analyses revealed that the impairment of 
patients partially correlated with the severity of negative symptoms as measured on the Positive 
and Negative Syndrome Scale but that it was not related to antipsychotic dose. In conclusion, 
the present study showed that the schizophrenia patients had impaired reward-based learning 
and that this was independent from their medication status.
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Introduction
The world that we are living in is constantly changing and survival is based on 
learning both the reward and the penalty information associated with changing 
contingencies. During evolution, animals increased their ability to adapt their 
responses or actions to environmental stimuli depending on trial-to-trial feedback 
(reward or punishment) after each response or action. This cognitive process is called 
feedback-driven reinforcement learning, which leads to the development of actions 
to maximize the reward or minimize the penalty in the long run.1,2 Accumulated data 
suggest that reward-related reinforcement learning takes place in the corticostriatal 
network, which mainly consists of the basal ganglia, the dorsolateral prefrontal 
cortex, and the orbitofrontal cortex (reviewed in a recent paper by Fareri et al3). 
Furthermore, reward prediction error, which is the process by which human beings 
become able to use past and current events to predict future events, is conveyed by 
midbrain dopamine neurons for new behavioral acquisition associated with 
contingency changes.4 In the face of any certain contingency, humans make the best 
prediction for that contingency based upon previous experiences. However, if the 
prediction is wrong (prediction error), then the knowledge base is updated so that 
future predictions are more accurate. Human imaging studies have revealed that the 
activity in the dopamine-rich ventral striatum and putamen is correlated with the 
reward prediction errors in classical conditioning tasks.1,5–7
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Schizophrenia is a severe mental disorder that affects 
nearly 1% of the population. Despite rigorous research 
efforts, the pathophysiology of the disease is only partially 
understood. One of the most popular theories on the 
pathophysiology of schizophrenia is dysfunctional dopamine 
transmission.8 Evidence supporting this theory includes the 
fact that pharmacological applications that intervene in 
dopamine transmission attenuate the positive symptoms. 
The caveat of this intervention is the possibility of increasing 
the negative symptoms and having only a limited benefit for 
the cognitive symptoms.9 Other supporting evidence comes 
from functional neuroimaging studies. Dopamine-based 
reward prediction error signal has been shown to diminish 
in schizophrenia patients, suggesting that patients fail to 
distinguish between relevant and irrelevant feedback 
signals.10 Further supporting evidence comes from clinical 
observations. Two negative symptoms, anhedonia and avoli-
tion, are closely related to dysfunctional reward processing, 
in that the reward is associated with the feeling of pleasure 
and any decrease in this feeling of pleasure would undermine 
motivation for goal-directed behavior, as the achievement 
of behavioral goals would result in an attenuated reward 
experience.11,12 Because reward function is a teaching signal 
about which stimuli and which responses are valued out-
comes, a deficit in reward functioning may lead to a decrease 
in the learning of value of stimuli and action selection in 
schizophrenia patients. Furthermore, inability to follow the 
reward-associated contingency changes may contribute to 
the impairment in the decision-making processes in schizo-
phrenia.13 It is proposed that feedback-driven reinforcement 
learning, which is related to the cortical dopamine system, 
is altered in schizophrenia patients.14 However, the results 
of studies are heterogeneous and inconclusive, with some 
studies showing impairment and the others showing no 
impairment, as reviewed by Gold et al.15 One reason for this 
may be the heterogeneity of patient groups, because it was 
shown that first-episode and chronic patients performed 
differently in the cognitive tests.16,17 The other reason may 
be the variability of the reinforcement tasks.18 The contin-
gencies and the reward value of feedback, which might have 
had different neural correlates, may be a factor that con-
founds results.
The aim of this study was to test the hypothesis that 
reward-related probability learning is altered in schizophrenia 
patients. To test this hypothesis, we used a gambling paradigm 
as the reward-related probability-learning task, using Turkish 
lira as the reward currency. Delgado et al19 employed this 
same gambling paradigm; it has been shown that the 
task specifically activates frontostriatal systems where 
reinforcement-related learning takes place. We preferred to 
recruit stable outpatients for two reasons: (1) these patients 
had minimal positive symptoms, which otherwise might have 
interfered in their performance during the experiment, and 
(2) stable outpatients are candidates for outpatient treatment 
programs, which have an objective to improve negative and 
cognitive symptoms of schizophrenia. Therefore, understand-
ing possible deficits in the reinforcement mechanisms of 
schizophrenia patients may help to develop better outpatient 
treatment programs.
Methods
Participants
Twenty-five schizophrenia patients and 25 healthy control 
subjects participated in the study. The schizophrenia patients 
were recruited from the outpatient clinic of the Department 
of Psychiatry, Ege University School of Medicine, only if 
they had been followed up for more than 1 year and were 
clinically stable for the last 6 months. The controls were 
recruited from local advertisements. To keep the distribution 
of education level and gender similar across the groups, the 
controls were selected nonrandomly from the applicants. The 
clinical diagnosis of schizophrenia was verified using the 
Structured Clinical Interview for Diagnostic and Statistical 
Manual of Mental Disorders, Fourth Edition (SCID), and a 
comprehensive review of medical records. Controls were 
screened with the nonpatient version of the SCID. Exclusion 
criteria for participants included head trauma with loss of 
consciousness, any unstable medical or neurological disease 
like diabetes mellitus, or hypertension. Furthermore, any 
axis I disorder other than schizophrenia in patients and any 
axis I disorder in controls were also exclusion criteria. 
Controls with a history of bipolar disorder or any psychotic 
disease in first-degree relatives were also excluded from the 
study.
The Institutional Review Board of Ege University School 
of Medicine approved the study. Each participant had a clear 
description of the study before giving his or her consent. 
During the informed consent procedure, a first-degree rela-
tive accompanied each patient. The clinical status of each 
patient was evaluated with the Positive and Negative Syn-
drome Scale (PANSS) and the Calgary Depression Scale.20,21 
The extrapyramidal symptoms were assessed with the 
Extrapyramidal Symptom Rating Scale (ESRS). The experi-
ment protocol began the following day. Because many of 
the patients had difficulty waking early, the experiment took 
place in the afternoon between 14:00 and 16:00.
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All the patients except one were on atypical   antipsychotics 
(clozapine, quetiapine, olanzapine, and risperidone; zuclo-
penthixol was the exception as a typical antipsychotic). Mean 
chlorpromazine-equivalent dosages are given in Table 1.
Before the task began, each participant scored his or her 
motivation and alertness on a scale from 1 to 10. Those who 
scored lower than 5 were excluded from the study.
Task
The gambling paradigm contained a series of 120 interleaved 
trials, with each trial lasting 11 seconds. The goal for each 
participant was to maximize his or her attained rewards by 
learning probabilities over time. Participants were instructed 
that during each 11-second trial, they would be shown a card 
with an unknown value ranging from 1 to 9. The participants 
were required to guess whether the value of the card was less 
than or greater than 5 (the card value could not be 5). Correct 
guesses led to positive feedback (a monetary reward) and 
incorrect guesses led to negative feedback (a monetary 
penalty). Each trial consisted of a probabilistic cue period 
followed by a feedback period. The probabilistic cue period 
began with one of five different cues (circle, diamond, square, 
star, and triangle) presented for 1.5 seconds on a 22-inch 
screen set 2 m away from the participants. Each cue repre-
sented the probability that the card to be shown in that 
  particular trial had a value higher or lower than the number 5. 
The probabilities were 100% (high or low), 67% (high or low), 
and 50% (random). At the end of the probabilistic cue 
period, the card to be shown during that particular trial was 
presented, with a question mark on it, on the screen.   Participants 
had to respond within 2.5 seconds by either a left- or a right-
click of a computer mouse to indicate their selection. After 
the choice was made, the number appeared on the card and 
positive or negative feedback was given: either a happy cartoon 
face with an upward green arrow (indicating a gain) or a sad 
cartoon face with a downward red arrow (indicating a loss) 
was shown. Each correct guess added TL1.00 to a patient’s 
account and each incorrect guess lost TL0.50. The account 
total of each participant was always displayed on the left side 
of the screen, represented by a bar, with the height of the bar 
changing with each gain or loss made.
Before the trials, participants were instructed to pay atten-
tion to the cues presented at the beginning of the trials and that 
each of the five cues represented a different probability regard-
ing the card value that was then shown. Participants were not 
told the contingencies before playing. Each cue was presented 
24 times during the experiment for a total of 120 trials in 12 
blocks. The cue order was random in each block and cues were 
not repeated consecutively. Participants were compensated 
according to their performance, although TL15.00 was guar-
anteed as a minimum for each participant.
Trials where a response was not made in time carried a 
monetary penalty of TL1.00. Repeated nonresponse or per-
severative mouse click were exclusion criteria (none of the 
participants met these criteria).
Statistical analyses
Clinical, demographic variables were compared by Student’s 
t test or chi-square test, depending on the type of variable. The 
total monetary score of each group, which was used as a 
measure of the performance (total amount earned, taking into 
account rewards, punishments, and missed trials), was com-
pared by Mann-Whitney U test because the variances between 
the groups were not similar. Each participant’s accuracy scores 
were obtained for each cue. The two cues with 100% probabil-
ity were combined to form the 100% probability condition, 
and the cues with 67% probability were combined to form the 
67% probability condition. A repeated measure of analysis of 
variance (ANOVA) model was used to compare the accuracy 
scores and reaction times for each cue. Pearson correlation 
coefficient analysis was preferred for testing the correlation 
between amounts of money earned or the accuracy rates and 
clinical variables. Statistical significance was set at P = 0.05.
Table  1  Clinical  and  demographic  variables  of  patients  and 
controls
Variable Schizophrenia 
patients (n = 25)
Controls  
(n = 25)
Comparison
Age (years) 30.1 ± 8.4 30.8 ± 8.4 t = 0.3; df = 48; 
P . 0.05
Gender (male/female) 13/12 14/11 χ2 = 0.1; df = 1; 
P . 0.05
Education (years) 12.8 ± 2.8 14.2 ± 5.4 t = 1.2; df = 48; 
P . 0.05
PANSS score
  Positive 12.3 ± 5.9 NA NA
  Negative 17.7 ± 10 NA NA
    General 
psychopathology
28.7 ± 13.5 NA NA
  Total 58.4 ± 27.3 NA NA
ESRS score 5.9 ± 6 NA NA
Calgary Depression  
Scale score
3.7 ± 4.9 NA NA
Antipsychotic dose* 
(mg)
220.3 ± 129.3 NA NA
Total performance 
score**
36.6 ± 17.4 53.8 ± 11.7 t = 4.4; df = 48; 
P , 0.001
Notes: *Chlorpromazine-equivalent dose (mg); **amount of money earned in the 
gambling task (TL).
Abbreviations: χ2, chi-square; df, degree of freedom; ESRS, Extrapyramidal Symptom 
Rating Scale; NA, not applicable; PANSS, Positive and Negative Syndrome Scale.
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Results
As Table 1 shows, patient and control groups were similar 
in age, gender distribution, and education level.   Schizophrenia 
patients had minor extrapyramidal and depressive symptoms. 
When the total amount of money earned by the end of the 
experiment was compared between the two groups, the 
healthy controls had earned more money than the patients 
(U = 132.5; P , 0.001).
When the accuracy scores were compared according to 
cues with repeated measure ANOVA, we observed a significant 
group effect (F = 16.8; degrees of freedom [df] = 1, 48; 
P , 0.001). Furthermore, we observed a significant cue effect 
(F = 62.6; df = 2, 96; P , 0.001) and interaction between cue 
and group (F = 8; df = 2, 96; P , 0.001).   Multivariate ANOVA 
showed the schizophrenia patients had significantly lower 
accuracy rates than the healthy controls in cues with 67% 
probability (F = 4.22; df = 1, 48; P = 0.04) and 100% 
probability (F = 25; df = 1, 48; P , 0.001) (Figure 1). 
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Figure 1 Accuracy rates and reaction times of schizophrenia patients and controls.
Table  2  Correlation  matrix  among  clinical  parameters  with 
the total performance scores (amount of money earned in the 
gambling task) and the accuracy scores
Clinical  
parameters
Total 
performance 
scores
Accuracy scores
50% 67% 100%
PANSS
  Positive -0.042 -0.05 -0.051 0.018
  Negative -0.03 0.17 0.171 -0.38*
    General  
psychopathology
-0.16 0.16 -0.22 -0.18
  Total -0.24 0.13 -0.193 -0.23
ESRS -0.013 0.3 -0.31 -0.087
Calgary  
Depression Scale
-0.088 0.25 -0.14 -0.12
Antipsychotic dose** -0.122 -0.13 -0.14 -0.51
Notes: *P = 0.06; **Chlorpromazine-equivalent dose.
Abbreviations: ESRS, Extrapyramidal Symptom Rating Scale; PANSS, Positive and 
Negative Syndrome Scale.
Both groups achieved similar results for cues with 50% 
  probability (F = 1.34; df = 1, 48; P . 0.05).
Although the patients’ reaction times were shorter than 
reaction times of the controls, the difference between 
groups was not statistically significant (F = 2.76; df = 1, 
48; P . 0.05). However, there were effects of cue exposure 
on reaction times (F = 4.46; df = 1, 47; P = 0.013) and cue 
and group interaction (F = 6.26; df = 1, 47; P = 0.004). 
Schizophrenia patients responded more slowly on cues 
with 50% probability (F = 4.8; df = 1, 48; P = 0.03) and 
showed a tendency to be slower on cues with 100% prob-
ability (F = 3.5; df = 1, 48; P = 0.07) (Figure 1).
We observed a correlation close to statistical significance 
between the negative subscale of PANNS scores and the 
accuracy rate of the 100% probability condition (r = -0.38; 
P = 0.06). The other correlation analyses revealed that clinical 
symptoms (PANSS and its subscales, Calgary Depression 
Scale scores, and ESRS scores) and antipsychotic doses had 
no correlation with the amount of money earned or the accu-
racy scores (Table 2).
Discussion
The results of the present study showed that stable schizo-
phrenia outpatients had impairment in reward-related proba-
bilistic learning based on affective feedback. The patients 
had lower scores than the controls in contingencies associated 
with moderate uncertainty; however, interestingly, their 
scores were worse in responding following stimulus 
  contingencies that could be fully predicted. Both groups had 
similar scores in stimulus where learning was impossible 
(50%   probability). Low scores in the Calgary Depression 
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Scale and the ESRS suggest that the findings were 
  independent from depressive mood of the patients and from 
extrapyramidal side effects of antipsychotics.
In recent years, neurobiological mechanisms under rein-
forcement learning have been studied extensively. The results 
of the many studies have helped people to better understand 
the role of striatal dopamine and its association with other 
brain systems (eg, the prefrontal lobe) in reinforcement 
learning.22,23 An impaired dopamine system and a dysfunc-
tional prefrontal cortex are also at the center of schizophrenia 
pathophysiology and have been reported on in many 
studies.24,25 Collected data from different studies suggest that 
schizophrenia patients have impaired performance on tests 
of rule learning that rely on hypothesis learning. One of the 
most studied examples of this finding is the reduction in the 
number of categories achieved by patients undergoing the 
Wisconsin Card Sorting Test.26 Schizophrenia patients have 
also shown impairment on conditional associative learning 
tests, which require them to use feedback to learn one-to-one 
stimulus-response mapping.27,28 However, the results of stud-
ies using unsupervised learning tasks that did not require the 
integration of trial-by-trial feedback at all – rather, involving 
incidental learning through repeated stimulus exposures or 
repeated performance of specific routines – did not show 
substantial difference between schizophrenia patients and 
controls.29–31 Kéri et al30 used a probabilistic category learning 
(PCL) task and showed that the performance of schizophrenia 
patients was as good as that of controls. However, when the 
investigators wanted patients to recognize the cues, patients 
had an impaired performance. Therefore, investigators con-
cluded that schizophrenia patients were successful in implicit 
learning but not in explicit learning. Other studies also 
resulted in these findings.29,31 Implicit learning is thought to 
occur without conscious awareness, operating largely inde-
pendently from the frontohippocampal systems of explicit 
learning but largely dependent on intact dopaminergic and 
basal ganglia functioning.32 These results seem contrary to 
neuroimaging findings that showed altered dopamine trans-
mission in the basal ganglia of schizophrenia patients.33 
A recent functional magnetic resonance imaging (fMRI) study 
showed that schizophrenia patients use other parts of the brain 
such as the rostral region of the dorsolateral prefrontal cortex, 
the cingulated cortex, the parahippocampal cortex, and the 
inferior parietal cortex to compensate for the reduced activity 
in the frontostriatal system and thereby to achieve performance 
similar to that of controls in implicit learning.34
The studies mentioned above used tasks that gave feed-
back to the patients depending on their response to stimuli. 
However, there were no rewards or penalties associated with 
feedback. This might have led to a lack of motivation to use 
the reinforcement to learn and guide future behavior, which 
makes a great deal of intuitive sense in both schizophrenia 
patients and controls. One way to overcome this problem is 
to use an affective feedback in the task such as money, as in 
the present study and others.35–37 Indeed, Knutson et al38 found 
that the activity in the caudate nucleus and ventral striatum 
correlated with the affective value of the anticipated monetary 
reward if subjects successfully hit a button during the display 
of a briefly presented target.
Adding feedback with affective value in the task may 
bring its own penalty in schizophrenia studies. Because it is 
proposed that anhedonia, as a symptom of the disease, may 
decrease the feeling of pleasure, then achieving behavioral 
goals does not result in the experience of pleasure, which 
provides little reason for vigorous pursuit of the goal. 
However, the majority of studies using different stimulus types 
and paradigms showed that schizophrenia patients, compared 
with healthy controls, report that they experience similar levels 
of valence and arousal to both negative and positive stimuli.39–41 
Therefore, the results obtained from this study and similar 
studies cannot be explained by diminished reward value of the 
feedback (see Gold et al18 for further discussion on this).
We observed that the schizophrenia patients had the worst 
performance on the 100% probability condition (ie, the 100% 
stimulus-outcome contingency), whereas the difference 
between the groups in predicting the 67% probability condi-
tion (ie, the 67% stimulus-outcome contingency) was mod-
erately significant. The finding of impaired performance of 
schizophrenia patients in full predictable conditions was in 
parallel with previous studies.36,42 As the 100% stimulus-
outcome contingency is the condition in which feedback is 
entirely unambiguous, learning is most rapid and easy in 
healthy people.19,42 Thus, we propose that patients are less 
sensitive to reward and error information in full predictable 
conditions than in partly predictable conditions. This proposal 
is based on Morris et al’s42 study that examined error-related 
negativity (ERN), which is related to error monitoring in 
schizophrenia using a probability-learning task. They found 
that ERN amplitude reduction was more marked in the 100% 
probability condition than the 80% probability condition. 
In the present study, we consider the patients’ slower response 
to cues with 100% probability was because of an impaired 
evaluation of error monitoring.
In this study, a gambling paradigm was used that showed 
activity in the caudate nucleus during the trial-and-error 
learning in a previous study.19 Thus, our finding of reduced 
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reward-related probability learning suggests schizophrenia 
patients have altered frontostriatal system. In a recent fMRI 
study, Koch et al36 used a task very similar to the one used 
in the present study and found that schizophrenia patients 
had significantly impaired reward-related trial-and-error 
learning associated with altered activation in frontoparietal 
networks in addition to frontostriatal systems.
In the present study, the finding of impaired implicit 
learning of repeated cues was contrary to previous studies 
that showed no impairment in implicit learning of schizo-
phrenia patients.29–31,43 The different results among the studies 
might have been because of the task used. Adding an affective 
component to the task might have led to the “overload” of the 
frontostriatal system and other, compensating brain systems 
of the patients, resulting in failure of the implicit learning. 
Similar phenomena were described and shown in a study of 
the working memory of schizophrenia patients.44,45
As negative symptoms like anhedonia and avolition are 
related to the reward system, it has been proposed that altered 
feedback learning may be related to the severity of negative 
symptoms. Indeed, patients who had prominent, primary 
negative symptoms had a negative correlation with the 
reinforcement-based learning.16,46 Primary negative symp-
toms should not be due to depression or anxiety, they should 
not be an antipsychotic side effect, and they should not be 
secondary to positive symptoms or psychosocial deprivation.47 
In the present study, the result of a trend-level significance 
between negative symptom subscale scores on the PANSS 
and accuracy rates of cues with 100% probability, in which 
the patients showed the most impairment, supports the 
findings of previous studies. As a group, the patients had lower 
Calgary Depression Scale and ESRS scores and had minimal 
psychotic symptoms. Therefore, we consider that the PANSS 
negative symptom scores of the patients mostly reflected the 
primary negative symptoms of the disease.
One of the main limitations of the study came from a 
software error that prevented us from presenting the effect 
of time on learning in each group. Although one study has 
shown there was no interaction between time and group in 
PCL in schizophrenia patients and healthy controls,34 another 
study suggested learning rates were different between 
groups.36 Furthermore, it was shown that as the reinforcement 
learning progresses, neural correlates are changed in healthy 
controls and the caudate nucleus becomes less activated.19 
The gambling test used in this study requires working 
memory for the best performance, and it has been shown that 
the working memory performance of schizophrenia patients 
is impaired. To reduce the memory load, the 120 trials were 
split into twelve blocks where each cue was presented twice. 
However, we are aware that this manipulation in the task was 
not enough to fully eliminate the effect of impaired working 
memory on the performance of the patients.   Alternatively, it 
should be kept in mind that the gambling test is related to 
implicit learning and depends on frontostriatal rather than 
frontohippocampal systems.
The other limitation of the study was the medication status 
of patients. It is well known that antipsychotics reduce dop-
amine transmission, leading to functional and structural 
changes.24,48,49 In spite of this, we did not observe a negative 
correlation between antipsychotic dose and reward-related 
probability learning in the patients. This finding was in line 
with a previous study that included schizophrenia patients 
with similar clinical and medication status.17 In the present 
study, most of the patients were receiving second-generation 
antipsychotics, which have lower dopamine antagonist activ-
ity than first-generation antipsychotics. Furthermore, fMRI 
studies showed that reward-related activity in the ventral 
striatum is unaffected by atypical antipsychotic treatment.25,50 
The patient group in the present study was recruited from 
schizophrenia patients with no other axis I disorder; this was 
done to eliminate the effects of comorbidity on the results. 
While applying the results of this study to the schizophrenia 
population, it should be kept in mind that comorbidity is a 
remarkably common situation in clinical practice. Although 
the patient and control groups had similar education status, 
this does not necessarily mean they had similar intelligence 
quotient (IQ) scores. Although implicit learning has been 
shown to be independent from IQ scores,51 missing IQ scores 
in the study population should be recognized as another 
limitation of this study.
Conclusion
The results of this study provide additional evidence for 
impaired reward-based learning in schizophrenia patients. 
Furthermore, the results showed the impairment was partially 
related to negative symptoms but was independent from the 
mood and medication status of patients.
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